WEBULL
WebtradeDownload

High Growth Tech Stocks To Watch In The US October 2026

Simply Wall St · 1d ago

The United States market has shown a positive trend, climbing 1.2% in the last week and up 13% over the past year, with earnings forecasted to grow by 18% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that not only capitalize on current technological advancements but also demonstrate strong potential for sustained earnings growth in line with broader market trends.

Top 10 High Growth Tech Companies In The United States

Name Revenue Growth Earnings Growth Growth Rating
Ciena 22.09% 35.00% ★★★★★★
TG Therapeutics 21.58% 21.57% ★★★★★★
Coherent 30.52% 43.85% ★★★★★★
Lumentum Holdings 33.89% 97.87% ★★★★★★
Insmed 32.16% 67.21% ★★★★★★
Madrigal Pharmaceuticals 27.87% 64.15% ★★★★★★
Shopify 20.17% 21.03% ★★★★★★
Travere Therapeutics 23.99% 53.11% ★★★★★★
Precigen 37.10% 54.04% ★★★★★★
Snowflake 21.06% 57.42% ★★★★★★

Click here to see the full list of 26 stocks from our US High Growth Tech and AI Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Precigen (PGEN)

Simply Wall St Growth Rating: ★★★★★★

Overview: Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company that focuses on developing gene and cell therapies with precision technology for diseases in immuno-oncology, autoimmune disorders, and infectious diseases, with a market cap of $2.70 billion.

Operations: The company's revenue primarily stems from its biotechnology startups, generating $85.72 million.

Precigen's recent FDA platform technology designation for its AdenoVerse immunotherapeutic platform marks a significant milestone, underscoring the company's innovative edge in biotechnology. This designation not only enhances the potential for rapid development of new therapies but also reflects on Precigen’s ability to leverage existing data and manufacturing processes efficiently. With a remarkable turnaround in financial performance, evidenced by a leap from $0.856 million to $54.98 million in quarterly revenue and transforming a substantial net loss into a $20.07 million profit within a year, Precigen demonstrates robust growth prospects. The company is poised for further advancements with expected annual revenue growth at 37.1% and earnings forecasted to surge by 54%.

PGEN Revenue and Expenses Breakdown as at Oct 2026
PGEN Revenue and Expenses Breakdown as at Oct 2026

Zymeworks (ZYME)

Simply Wall St Growth Rating: ★★★★★★

Overview: Zymeworks Inc. is a biotechnology company focused on developing biotherapeutics for cancer, inflammation, and autoimmune diseases, with a market cap of approximately $1.79 billion.

Operations: The company primarily generates revenue from the development of next-generation multifunctional biotherapeutics, amounting to $37.13 million.

Zymeworks, with its recent executive appointment and strategic acquisitions, is poised to enhance its technological capabilities in AI and machine learning, crucial for advancing biotech innovations. Despite a challenging Q2 with a net loss of $45.02 million, the company's aggressive share repurchase program underscores confidence in its financial strategy. Looking ahead, Zymeworks anticipates significant revenue boosts from upcoming U.S. approvals and global regulatory milestones potentially totaling $440 million, aligning with an expected annual revenue growth of 25.3% and profit growth forecasts at 47.7%. This strategic positioning may catalyze its transition to profitability within three years amidst an industry where rapid innovation is paramount.

ZYME Earnings and Revenue Growth as at Oct 2026
ZYME Earnings and Revenue Growth as at Oct 2026

Snowflake (SNOW)

Simply Wall St Growth Rating: ★★★★★★

Overview: Snowflake Inc. offers a cloud-based data platform serving organizations globally, with a market capitalization of $117.31 billion.

Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $5.43 billion.

Snowflake's strategic initiatives, including its recent partnerships and product developments, underscore its commitment to integrating AI deeply into data analytics and management. Hosting the Snowflake Expedition 2026 highlights its pivot towards broadening AI accessibility across business functions, promising enhanced agentic workflows and data connectivity. Moreover, the expansion of its partnership with UiPath exemplifies a strong focus on seamless automation integration without data silos, enhancing operational efficiency for joint customers. This approach not only aligns with an annual revenue growth forecast of 21.1% but also positions Snowflake at the forefront of leveraging AI within cloud-based data ecosystems to drive substantial market differentiation.

SNOW Earnings and Revenue Growth as at Oct 2026
SNOW Earnings and Revenue Growth as at Oct 2026

Key Takeaways

  • Gain an insight into the universe of 26 US High Growth Tech and AI Stocks by clicking here.
  • Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
  • Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.